Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Buy
742,927
+276,649
+59% +$7.24M 0.08% 221
2026
Q1
$13.1M Buy
466,278
+145,582
+45% +$3.88M 0.06% 294
2025
Q4
$7.99M Sell
320,696
-125,924
-28% -$3.18M 0.02% 403
2025
Q3
$11.4M Buy
446,620
+235,941
+112% +$5.82M 0.03% 298
2025
Q2
$5.11M Sell
210,679
-75,441
-26% -$1.76M 0.03% 417
2025
Q1
$7.25M Sell
286,120
-34,352
-11% -$899K 0.06% 255
2024
Q4
$8.5M Buy
320,472
+40,117
+14% +$1.09M 0.08% 160
2024
Q3
$8.11M Buy
280,355
+55,719
+25% +$1.63M 0.1% 140
2024
Q2
$6.29M Buy
224,636
+30,388
+16% +$837K 0.08% 154
2024
Q1
$5.39M Buy
194,248
+42,295
+28% +$1.17M 0.08% 166
2023
Q4
$4.37M Buy
151,953
+23,847
+19% +$721K 0.07% 177
2023
Q3
$4.25M Sell
128,106
-102,657
-44% -$3.63M 0.09% 153
2023
Q2
$8.46M Buy
230,763
+12,240
+6% +$476K 0.17% 91
2023
Q1
$8.92M Sell
218,523
-12,039
-5% -$520K 0.21% 80
2022
Q4
$11.8M Buy
230,562
+33,908
+17% +$1.63M 0.33% 60
2022
Q3
$8.61M Sell
196,654
-40,685
-17% -$1.98M 0.24% 71
2022
Q2
$12.4M Buy
237,339
+6,516
+3% +$332K 0.38% 48
2022
Q1
$11.9M Buy
230,823
+35,960
+18% +$1.87M 0.28% 57
2021
Q4
$11.5M Buy
194,863
+17,701
+10% +$877K 0.27% 59
2021
Q3
$7.62M Buy
177,162
+33,491
+23% +$1.48M 0.2% 69
2021
Q2
$5.63M Buy
143,671
+14,563
+11% +$566K 0.17% 86
2021
Q1
$4.68M Sell
129,108
-5,260
-4% -$187K 0.19% 82
2020
Q4
$4.95M Buy
134,368
+5,403
+4% +$198K 0.22% 77
2020
Q3
$4.49M Buy
128,965
+4,704
+4% +$165K 0.24% 65
2020
Q2
$3.85M Buy
124,261
+44,335
+55% +$1.51M 0.25% 69
2020
Q1
$2.48M Buy
79,926
+13,767
+21% +$469K 0.2% 77
2019
Q4
$2.46M Buy
+66,159
New +$2.36M 0.22% 78

Other funds holding PFE

IEQ Capital's PFE Position: Q2 2026 in Review

IEQ Capital increased its Pfizer (PFE) stake by 59% in Q2 2026, buying an estimated $7.24M and bringing the position to 742,927 shares worth $17.9M. The position accounts for 0.08% of the portfolio, ranked #221.

IEQ Capital first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • IEQ Capital held 742,927 shares of Pfizer worth $17.9M as of Q2 2026.
  • IEQ Capital bought 276,649 Pfizer shares in Q2 2026, an estimated $7.24M.
  • Pfizer made up 0.08% of IEQ Capital's portfolio in Q2 2026, its #221 holding.
  • IEQ Capital first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.